Litcius/Paper detail

Off‐Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk‐Benefit Profile

Sudhakar M. Pai, Jean‐Michel Gries

2021The Journal of Clinical Pharmacology13 citationsDOI

Topics & Concepts

KetamineMedicineDrugIntensive care medicinePharmacologyAnesthesiaTreatment of Major DepressionAnesthesia and Sedative AgentsPharmaceutical studies and practices
Off‐Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk‐Benefit Profile | Litcius